Your session is about to expire
← Back to Search
Quality Improvement for Cancer Screening Outcomes
N/A
Waitlist Available
Led By Pamela C Hull, PhD
Research Sponsored by University of Kentucky
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial will test whether practice facilitation, or helping healthcare providers and staff with cancer prevention and screening guidelines, can improve cancer outcomes.
Who is the study for?
This clinical trial is open to normal volunteers who are interested in participating. There are no specific exclusion criteria, meaning that the study is quite inclusive and anyone willing can potentially join.Check my eligibility
What is being tested?
The trial is testing a Quality Improvement Practice Facilitation Intervention aimed at helping healthcare providers and staff better follow cancer prevention and screening guidelines in primary care settings.See study design
What are the potential side effects?
Since this intervention involves practice facilitation rather than medication or medical procedures, there aren't typical side effects. Participants may experience changes in workflow or increased administrative tasks.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Colorectal Cancer: Screening Rate (Patient Population)
Lung Cancer: Screening Rate (Patient Population)
Tobacco: Treatment Rate (Patient Population)
Trial Design
1Treatment groups
Experimental Treatment
Group I: Interventional ArmExperimental Treatment1 Intervention
Intervention
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,093 Total Patients Enrolled
University of KentuckyLead Sponsor
185 Previous Clinical Trials
226,582 Total Patients Enrolled
Pamela C Hull, PhDPrincipal InvestigatorUniversity of Kentucky
1 Previous Clinical Trials
420 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Not applicable.
Research Study Groups:
This trial has the following groups:- Group 1: Interventional Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Do you have any additional openings for candidates to join this experiment?
"Unfortunately, this clinical trial is not currently enrolling participants. Despite being posted on April 29th 2022 and last updated November 8th 2022, it has yet to start recruiting. However, there are 485 other trials actively searching for patients at the moment."
Answered by AI
Is there the possibility to join this experiment?
"This medical study is actively recruiting 60 individuals aged 18-99 with malignancies, as well as healthy volunteers."
Answered by AI
Are individuals who are 40 years of age or older being considered for inclusion in this trial?
"Eligibility criteria for this experiment necessitates that potential participants are between 18 to 99 years of age."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger